← FDA DRUG APPROVALS

FDA ANDA · ANDA065266

CLARITHROMYCIN

Sponsor: WOCKHARDT

APPLICATION
ANDA065266
TYPE
ANDA
ORIGINAL APPROVAL
2006-05-31
LATEST ACTION
2014-09-17
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CLARITHROMYCINDiscontinued
CLARITHROMYCIN 250MG · TABLET · ORAL
CLARITHROMYCINDiscontinued
CLARITHROMYCIN 500MG · TABLET · ORAL

Approval history

2014-09-17Labeling · Supplement 2 · standardAP
2006-05-31Original — Other Important Information from FDA ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →